September 2010 Issue Point of View: Gauging Regulatory Effectiveness
By Bikash Chatterjee
That the pharmaceutical and biotech industry is in a state of flux is undeniable.
Who Is To Blame For Critical Cleaning?
By John B. Durkee, Ph.D., P.E.
This is one of those columns you have to read (and write) every couple of years or so.
Art & Technology
By Barbara Kanegsberg, Ed Kanegsberg, Chris Stavroudis
On the surface, critical cleaning/contamination control and art conservation seem worlds apart.
Now We're Talking! (A Conversation With Dr. Clayton Teague)
By Ahmad Soueid, AIA, LEED® AP
In 2001, the federal government launched the U.S. National Nanotechnology Initiative, (NNI), with an initial investment of $500 million.
Beyond NIST-Traceability: What Really Creates Accuracy
By Bruce McDuffee
“NIST-traceable” is often invoked as though it has some sort of magical metrological power, imparting accuracy to all it touches.
Following ESD Materials Validation Protocols - Part 1
By Bob Vermillion
Comparing Antistats versus Inherently Conductive Polymer Coated Type I Moisture Barrier Bags for Humidity Dependence & Charge Generation at Low RH
Deciphering The Regulations For Facility Design and Environmental Control
By Wai Wong
With the FDA under fire in recent years regarding the quality of inspections, the effect has been to err on the safe side of regulatory requirements by proving more evidence.